IGF-1 LR3 IGF-1 LR3 is a modified form of insulin-like growth factor-1 with an arginine substitution at position 3 and a 13-amino acid N-terminal extension, designed to have reduced binding to IGF-binding proteins, which increases its free, biologically active fraction and potency
It produces a sharper, more pulse-like effect that fades quickly, which is closer to how the body naturally releases growth hormone in bursts
Because Tesamorelin is a GHRH analog, the research/clinical framing tracks IGF-1 (to avoid excessive elevation) and blood glucose (GH is counter-regulatory to insulin)
The most important goal is reducing long-term complications
I learned this the expensive way: chasing miracle serums doesnt
The breakage of the -glutamyl bond catalyzed by GGT can alter the dispersed state of the probe and trigger both the AIE and ESIPT effects